Figure S1: A methylation-associated nomogram for predicting the recurrence survival risk of stage I-III lung adenocarcinoma.tif

<div> <table> <tr> <td> <p><b>Supplementary Figure 1</b>. A methylation-associated nomogram for predicting the recurrence survival risk of stage I-III lung adenocarcinoma</p> <p><i>“High Risk” and “Low Risk” represent the high- and low-risk groups, respectively. The cutoff was defined as the median risk score. Y-axis represent the β-value of 14-DNA methylation sites. The differences between the 2 groups were estimated by Mann-Whitney U test.</i></p> </td> </tr> </table> </div>